Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 4/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GRM8 | O00222 | 1/20 | 0.31 |
| ▸ | GRM6 | O15303 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9565484 | 1.00 | GRM4 (0.31) | GRM4CYP2C19MEN1ALDH1A1CYP1A2 | |
| SCHEMBL9565510 | 0.81 | GRM4 (0.32) | GRM4CYP2C19MEN1ALDH1A1CYP1A2 | |
| SCHEMBL9565506 | 0.81 | GRM4 (0.32) | GRM4CYP2C19MEN1ALDH1A1CYP1A2 | |
| SCHEMBL8018705 | 0.78 | GRM4 (0.32) | GRM4CYP2C19MEN1ALDH1A1CYP1A2 | |
| SCHEMBL8018708 | 0.78 | GRM4 (0.32) | GRM4CYP2C19MEN1ALDH1A1CYP1A2 | |
| SCHEMBL8015707 | 0.78 | GRM4 (0.32) | GRM4CYP2C19MEN1ALDH1A1CYP1A2 | |
| SCHEMBL8689120 | 0.75 | — | — | |
| SCHEMBL8781711 | 0.75 | — | — | |
| SCHEMBL8781714 | 0.75 | — | — | |
| SCHEMBL9565490 | 0.73 | MMP1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0554025-A2 | Fluorinated cyclobutyl purines and pyrimidines | E.R. SQUIBB & SONS, INC. (US) | 1993-08-04 | — | — | EP | disclosed |